It is estimated that 10% of the medicine in the world are counterfeits. In some market, the number reaches an astonishing 50%. Counterfeit medicine jeopardize people’s health, causing severe social problem. In order to safeguard medicine security, China has making more strict regulations in this field. The revised edition of GSP requiring pharmaceutical enterprises establishing tracing system. With many years’ experience, CCN is able to assist enterprises in building a reliable tracing system, fulfilling the need of enterprises management and government supervision.